CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
240.18B
FKIQX
Price
$2.37
Change
+$0.01 (+0.42%)
Updated
Jan 17 closing price
Net Assets
73.59B
Ad is loading...

CLBCX vs FKIQX

Header iconCLBCX vs FKIQX Comparison
Open Charts CLBCX vs FKIQXBanner chart's image
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets240.18B
Franklin Income A
Price$2.37
Change+$0.01 (+0.42%)
VolumeN/A
Net Assets73.59B
CLBCX vs FKIQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. FKIQX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and FKIQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 240B vs. FKIQX (73.6B). FKIQX pays higher dividends than CLBCX: FKIQX (5.42) vs CLBCX (1.52). CLBCX was incepted earlier than FKIQX: CLBCX (23 years) vs FKIQX (6 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. FKIQX (56.23). CLBCX has a lower initial minimum investment than FKIQX: CLBCX (250) vs FKIQX (1000). CLBCX annual gain was more profitable for investors over the last year : 11.42 vs. FKIQX (9.83). FKIQX (27.78) and CLBCX (26.62) have equivalent 5 years return.
CLBCXFKIQXCLBCX / FKIQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years6 years-
Gain YTD1.8941.315144%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets240B73.6B326%
Annual Yield % from dividends1.525.4228%
Returns for 1 year11.429.83116%
Returns for 3 years11.248.66130%
Returns for 5 years26.6227.7896%
Returns for 10 years56.78N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin